Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.

Ma L, Zhou Z, Zhang D, Yang S, Wang J, Xue F, Yang Y, Yang R.

Thromb Haemost. 2012 May;107(5):937-50. doi: 10.1160/TH11-08-0596. Epub 2012 Mar 8.

PMID:
22398715
2.

The pathogenesis of chronic immune thrombocytopenic purpura.

McMillan R.

Semin Hematol. 2007 Oct;44(4 Suppl 5):S3-S11. doi: 10.1053/j.seminhematol.2007.11.002. Review.

PMID:
18096470
3.

Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications.

Batsali AK, Kastrinaki MC, Papadaki HA, Pontikoglou C.

Curr Stem Cell Res Ther. 2013 Mar;8(2):144-55. Review.

PMID:
23279098
4.

Perspectives of employing mesenchymal stem cells from the Wharton's jelly of the umbilical cord for peripheral nerve repair.

Ribeiro J, Gartner A, Pereira T, Gomes R, Lopes MA, Gonçalves C, Varejão A, Luís AL, Maurício AC.

Int Rev Neurobiol. 2013;108:79-120. doi: 10.1016/B978-0-12-410499-0.00004-6. Review.

PMID:
24083432
5.

Epidemiology and pathophysiology of immune thrombocytopenic purpura.

Gernsheimer T.

Eur J Haematol Suppl. 2008 Feb;(69):3-8. doi: 10.1111/j.1600-0609.2007.00998.x. Review.

PMID:
18211567
6.

Wharton's Jelly stem cells: future clinical applications.

Taghizadeh RR, Cetrulo KJ, Cetrulo CL.

Placenta. 2011 Oct;32 Suppl 4:S311-5. doi: 10.1016/j.placenta.2011.06.010. Epub 2011 Jul 6. Review.

PMID:
21733573
7.

Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?

El Omar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V.

Tissue Eng Part B Rev. 2014 Oct;20(5):523-44. doi: 10.1089/ten.TEB.2013.0664. Epub 2014 Apr 22. Review.

PMID:
24552279
8.

Umbilical cord revisited: from Wharton's jelly myofibroblasts to mesenchymal stem cells.

Corrao S, La Rocca G, Lo Iacono M, Corsello T, Farina F, Anzalone R.

Histol Histopathol. 2013 Oct;28(10):1235-44. doi: 10.14670/HH-28.1235. Epub 2013 Apr 18. Review.

PMID:
23595555
9.

A megakaryocyte with no platelets: anti-platelet antibodies, apoptosis, and platelet production.

Perdomo J, Yan F, Chong BH.

Platelets. 2013;24(2):98-106. doi: 10.3109/09537104.2012.669508. Epub 2012 Jun 28. Review.

PMID:
22742725
10.

Pathogenesis of immune thrombocytopenia.

Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B.

Autoimmun Rev. 2017 Jun;16(6):620-632. doi: 10.1016/j.autrev.2017.04.012. Epub 2017 Apr 17. Review.

PMID:
28428120
11.

Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.

Bakchoul T, Sachs UJ.

Hamostaseologie. 2016 Aug 3;36(3):187-94. doi: 10.5482/HAMO-14-09-0043. Epub 2015 May 18. Review.

PMID:
25982994
12.

Promising cellular therapeutics for prevention or management of graft-versus-host disease (a review).

McGuirk JP, Weiss ML.

Placenta. 2011 Oct;32 Suppl 4:S304-10. doi: 10.1016/j.placenta.2011.04.013. Epub 2011 Jun 11. Review.

13.

Interaction of Wharton's jelly derived fetal mesenchymal cells with tumor cells.

Bharathiraja C, Sukirtha R, Krishnan M, Achiraman S.

Curr Stem Cell Res Ther. 2014;9(6):504-7. Review.

PMID:
24804889
14.

Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis.

Khodadi E, Asnafi AA, Shahrabi S, Shahjahani M, Saki N.

Ann Hematol. 2016 Oct;95(11):1765-76. doi: 10.1007/s00277-016-2703-1. Epub 2016 May 28. Review.

PMID:
27236577
15.

The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage.

Semple JW, Provan D.

Curr Opin Hematol. 2012 Sep;19(5):357-62. doi: 10.1097/MOH.0b013e3283567541. Review.

PMID:
22759631
16.

Advances in immunopathogenesis of adult immune thrombocytopenia.

Liu X, Hou Y, Peng J.

Front Med. 2013 Dec;7(4):418-24. doi: 10.1007/s11684-013-0297-8. Epub 2013 Nov 21. Review.

PMID:
24264165
17.

Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation.

Stagg J, Galipeau J.

Curr Mol Med. 2013 Jun;13(5):856-67. Review.

PMID:
23642066
18.

Cellular immune dysfunction in immune thrombocytopenia (ITP).

McKenzie CG, Guo L, Freedman J, Semple JW.

Br J Haematol. 2013 Oct;163(1):10-23. doi: 10.1111/bjh.12480. Epub 2013 Aug 12. Review.

PMID:
23937260
19.

Novel treatments for immune thrombocytopenia.

Shih A, Nazi I, Kelton JG, Arnold DM.

Presse Med. 2014 Apr;43(4 Pt 2):e87-95. doi: 10.1016/j.lpm.2014.02.006. Epub 2014 Mar 20. Review.

20.

Cell death in immune thrombocytopenia: novel insights and perspectives.

von Gunten S, Wehrli M, Simon HU.

Semin Hematol. 2013 Jan;50 Suppl 1:S109-15. doi: 10.1053/j.seminhematol.2013.03.016. Review.

Supplemental Content

Support Center